Erin Catherine Carter

CIK: 0001993078

Transaction Breakdown

Open Market Buys (P)1 (9.1%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)8 (72.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (18.2%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GCTK

Glucotrack, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (11 total)

GCTK
Glucotrack, Inc.
Oct 3, 2025
Award(A)
Direct
386 shares-
GCTK
Glucotrack, Inc.
Jul 11, 2025
Award(A)
Direct
1K shares-
GCTK
Glucotrack, Inc.
Mar 26, 2025
Award(A)
Direct
1.9K shares-
GCTK
Glucotrack, Inc.
Mar 25, 2025
Award(A)
Direct
32 shares-
GCTK
Glucotrack, Inc.
Mar 12, 2025
In-the-Money(X)
Direct
40.3K shares-
GCTK
Glucotrack, Inc.
Nov 14, 2024
Award(A)
Series B Common Warrant
Direct
2.1K shares-
GCTK
Glucotrack, Inc.
Nov 14, 2024
Conversion(C)
Direct
2.1K shares at avg. $31.20$65K
GCTK
Glucotrack, Inc.
Nov 14, 2024
Award(A)
Series A Common Warrant
Direct
2.1K shares-
GCTK
Glucotrack, Inc.
Jul 18, 2024
Purchase(P)
Convertible Promissory Note
Direct
0 shares at avg. $50000.00-
GCTK
Glucotrack, Inc.
Apr 8, 2024
Award(A)
Direct
458 shares-
GCTK
Glucotrack, Inc.
Dec 31, 2023
Award(A)
Direct
903 shares-

		Type	Shares	Price		Ownership
Oct 3, 2025	GCTK Glucotrack, Inc.	Award(A)	386	-	-	Direct
Jul 11, 2025	GCTK Glucotrack, Inc.	Award(A)	1,000	-	-	Direct
Mar 26, 2025	GCTK Glucotrack, Inc.	Award(A)	1,896	-	-	Direct
Mar 25, 2025	GCTK Glucotrack, Inc.	Award(A)	32	-	-	Direct
Mar 12, 2025	GCTK Glucotrack, Inc.	In-the-Money(X)	40,297	-	-	Direct
Nov 14, 2024	GCTK Glucotrack, Inc.	Award(A) Series B Common Warrant	2,078	-	-	Direct
Nov 14, 2024	GCTK Glucotrack, Inc.	Conversion(C)	2,078	$31.20	$64,834	Direct
Nov 14, 2024	GCTK Glucotrack, Inc.	Award(A) Series A Common Warrant	2,078	-	-	Direct
Jul 18, 2024	GCTK Glucotrack, Inc.	Purchase(P) Convertible Promissory Note	0	$50000.00	-	Direct
Apr 8, 2024	GCTK Glucotrack, Inc.	Award(A)	458	-	-	Direct
Dec 31, 2023	GCTK Glucotrack, Inc.	Award(A)	903	-	-	Direct

1-11 of 11 transactions

About Carter Erin Catherine

Carter Erin Catherine (SEC CIK 0001993078) files insider reports with the SEC as Director of Glucotrack, Inc. (GCTK).

Signal8 holds 2 ownership filings by Carter Erin Catherine, all Form 4s, filed between Mar 31, 2025 and Oct 7, 2025. Those filings report 11 transactions, from Dec 31, 2023 to Oct 3, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Carter Erin Catherine's filings is in RUTHERFORD, NJ.

Recent filings by Carter Erin Catherine

Oct 3, 2025: Grant or award of GCTK shares (Form 4, code A).
Jul 11, 2025: Grant or award of GCTK shares (Form 4, code A).
Mar 26, 2025: Grant or award of GCTK shares (Form 4, code A).
Mar 25, 2025: Grant or award of GCTK shares (Form 4, code A).
Mar 12, 2025: Option exercise of GCTK shares (Form 4, code X).

Other insiders filing for Glucotrack, Inc. (GCTK)

CARR BRENDEL VICTORIA, Director
Balo Andrew K, Director
Malave Luis, Director
Goode Paul, Chief Executive Officer
John A. Ballantyne Revocable Living Trust dated 08/01/2017, 10% Owner
BALLANTYNE JOHN, Director

How to read Form 4 transaction codes